1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B
2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver In Journal of Hepatology 50(Suppl 1). p.232-232(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Is sustained virological response to HCV treatment associated with a clinical important improvement in vitality?
2008) 43rd Annual Meeting of the European Association for the Study of the Liver In Journal of Hepatology 48(Suppl. 2). p.272-272(
- Contribution to journal › Published meeting abstract